Back

Implementing point-of-care ketone testing and a 'three zone' ketone interpretation framework to predict dietary preparation and myocardial suppression in FDG PET for cardiac inflammation

30 August 2026 (13:15 - 13:45)
Organised by: Logo
Congress Presentation Part of: Novel positron emission tomography tracers in cardiomyopathy Inflammation, Infection, and Infiltrative Cardiovascular Disorders ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor George Benjamin Collins

Barts Health NHS Trust, London (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail
Cardiac amyloid imaging with [¹¹C]PIB PET/CT: insights from an initial clinical experience
Doctor P. Ventura (Coimbra, PT)
Abstract Slides Video
Presentation thumbnail
Cardiac fibroblast activation as a novel molecular imaging biomarker in hypertrophic cardiomyopathy: a prospective positron emission tomography study
Doctor T. Ramtoola (Edinburgh, GB)
Abstract Slides Video
Presentation thumbnail
Imaging the invisible: comparative diagnostic accuracy of cardiac imaging techniques for amyloidosis
Doctor N. Doobay (Brooklyn, US)
Abstract Slides Video
Presentation thumbnail
Myocardial inflammation imaging in fabry disease of the heart using somatostatin receptor PET/MRI
Doctor G. Collins (London, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Novel positron emission tomography tracers in cardiomyopathy

The Event

Event poster

ESC Congress 2026

30 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Heparin does not improve myocardial glucose metabolism suppression in patients with low betahydroxybutyrate level
30 August 2024
thumbnail
Congress Presentation
Exogenous ketosis fails to mitigate cardiac dysfunction, mitochondrial and inflammatory dysregulation in acute doxorubicin-induced cardiotoxicity
28 August 2026
thumbnail
Congress Presentation
Acylcarnitines as markers of early cardiometabolic dysregulation in a population-based sample of apparently healthy adults
28 August 2026
thumbnail
Congress Presentation
The second phase-3 multi-center trial of flurpiridaz F-18 PET myocardial perfusion imaging for coronary artery disease evaluation
27 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources